Sepetaprost
Sepetaprost (ONO-9054) is a dual agonist of the prostaglandin E3 receptor and prostaglandin F receptor. Sepetaprost reduces intraocular pressure in animal models. Sepetaprost is applicable for research on ocular hypertension and open-angle glaucoma.
For research use only. We do not sell to patients.
- CAS No.: 1262873-06-2
- Formula: C26H36F2O6
- Molecular Weight:482.56
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
|
EP3 |
FP Receptor |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male cynomolgus monkeys[2]
-
Dosage:0.002%
-
Administration:topical ocular instillation; single dose
-
Result:Significantly reduced IOP at 8, 10, 12, 26, and 28 h post-administration.
Showed consistently greater IOP-lowering effect than latanoprost at all measured time points.\nSignificantly enhanced outflow facility compared to vehicle.
Induced significant IOP reduction from baseline at 8, 24, and 26 h (IOP change from baseline: -1.3 mmHg at 8 h, -1.7 mmHg at 24 h, -1.4 mmHg at 26 h).
Had its IOP-lowering effect significantly attenuated at 26 h by pretreatment with an EP3 antagonist, with no significant differences observed at 8 or 24 h.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 1262873-06-2
-
Molecular Weight 482.56
-
Formula C26H36F2O6
-
SMILES
O=C(OC(C)C)CCC[C@H]1CC[C@@]([C@@H](/C=C/[C@@H](O)COC2=CC(F)=CC=C2F)[C@H](O)C3)([H])[C@@]3([H])OC1
-
Synonyms
ONO-9054
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Suto F, et al. A Novel Dual Agonist of EP3 and FP Receptors for OAG and OHT: Safety, Pharmacokinetics, and Pharmacodynamics of ONO-9054 in Healthy Volunteers. Invest Ophthalmol Vis Sci. 2015;56(13):7963-7970. [Content Brief]
[2]. Maki K, et al. The Role of EP3 Agonism in Intraocular Pressure-Lowering by Sepetaprost, a Novel Dual Agonist of FP and EP3 Receptors, in Monkeys. J Ocul Pharmacol Ther. 2026;42(3):172-178. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Sepetaprost Related Classifications
HY-128538 Related Classifications
Powered by Bioz